Instapath was featured in TechCrunch as one of 85 companies that launched during YCombinator's W19 Demo Day.

Our company was highlighted as such: "Cancer biopsies can take a week to get you your results. Instapath is building a fully-automated pathology lab that can test a tissue sample and provide a …

Instapath was a recipient of a prestigious seed grant awarded by the Cancer Prevention & Research Institute of Texas.

The Seed Award grants were funded from CPRIT’s Product Development Research Program. The goal of the new Seed Awards is to assist startup companies transfer translational research into product development to …

Instapath has been awarded a National Science Foundation (NSF) Small Business Technology Transfer (STTR) grant for $225,000 to conduct research and development (R&D) work on a novel imaging technology for point-of-care biopsy evaluation.

The biotechnology company makes a digital microscope that provides an exact picture of cancer biopsies within seconds. …